On August 26, 2020 ChromaDex Corp. (NASDAQ:CDXC) reported that its Chief Executive Officer, Rob Fried , and Chief Financial Officer, Kevin Farr , will be presenting at the LD 500 investor conference (Press release, ChromaDex, AUG 26, 2020, View Source [SID1234568254]). The LD 500 will take place on September 1st through the 4th.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The ChromaDex management team is scheduled to present on Wednesday, September 2, 2020 at 2:00 p.m. Eastern Time ( 11:00 a.m. Pacific Time ). The presentation will be webcast live via the link below on the investor relations section of the Company’s website at www.chromadex.com . ChromaDex management will also attend virtual one-on-one meetings with institutional investors throughout the day. For those interested in having a meeting with ChromaDex please contact David Scher at [email protected] or visit www.ldmicro.com for more information.